New Delhi, March 29, 2026 : Union Minister Jitendra Singh has cautioned that abdominal or central obesity poses a far greater health risk than overall obesity, especially among Indians, where even lean-looking individuals may carry harmful visceral fat.
Speaking at the release of the book “Advances in Obesity and Lipid Management in CVD”, edited by noted cardiologist H. K. Chopra, Dr. Singh emphasized that central obesity acts as an independent risk factor for multiple metabolic disorders.
He explained that excess fat around the abdomen significantly increases the risk of conditions such as Type 2 Diabetes, Hypertension, Cardiovascular Disease, Fatty Liver Disease, and lipid abnormalities—even in individuals who may not appear overweight.
Highlighting the “Indian phenotype,” Dr. Singh noted that abdominal obesity remains disproportionately high in the country and plays a critical role in increasing cardiometabolic risks. He stressed the need for early detection and targeted interventions to address visceral fat.
Linking the issue to national priorities, Dr. Singh said the publication aligns with Prime Minister Narendra Modi’s vision of a healthier India, promoting awareness and lifestyle changes such as reduced oil consumption and healthier dietary habits under the broader goal of “Vikshit Bharat, Swasthya Bharat.”
He also pointed to growing scientific evidence connecting abdominal fat with insulin resistance, early cardiac complications, and rising cases of metabolic diseases among younger populations—largely driven by sedentary lifestyles and poor dietary patterns.
Cautioning against extreme or unscientific fitness practices, the Minister underlined the importance of balanced health routines, proper rest, and sustained lifestyle discipline for long-term well-being.
The comprehensive textbook, featuring contributions from over 300 experts globally, marks a shift toward precision prevention in managing obesity and cardiovascular risks. It explores advanced therapies, including Semaglutide and Tirzepatide, alongside modern lipid-lowering strategies and AI-driven clinical approaches.
Dr. Singh described obesity and dyslipidemia as major public health challenges contributing to rising cardiovascular diseases in India and globally. He called for stronger awareness campaigns, early screening, and preventive healthcare to tackle the anticipated surge in obesity by 2050.
The book, comprising 23 sections and 172 chapters, is expected to serve as a vital resource for clinicians and researchers, bridging the gap between advanced research and practical patient care.
